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Microbial biocontainment is an essential goal for engineering safe, next-generation living therapeutics [1, 2].
However, the genetic stability of biocontainment circuits, including kill switches, is a challenge that must be
addressed. Kill switches are among the most difficult circuits to maintain due to the strong selection pressure
they impart, leading to high potential for evolution of escape mutant populations. We engineered two CRISPRbased kill switches in the probiotic Escherichia coli Nissle 1917, a single-input chemical-responsive switch and a
2-input chemical- and temperature-responsive switch. We employed parallel strategies to address kill switch
stability, including functional redundancy within the circuit, modulation of the SOS response, antibioticindependent plasmid maintenance, and provision of intra-niche competition by a closely related strain. We
demonstrate that strains harboring either kill switch can be selectively and efficiently killed inside the murine gut,
while strains harboring the 2-input switch are additionally killed upon excretion. Leveraging redundant strategies,
we demonstrate robust biocontainment of our kill switch strains and provide a template for future kill switch
development [3].
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Figure. Complete killing achieved by the optimized CRISPR kill-switch in vivo.

